Template:Cholangiocarcinoma: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
(15 intermediate revisions by 3 users not shown) | |||
Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma (patient information)|Patient | [[Cholangiocarcinoma (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 29: | Line 29: | ||
! | ! | ||
[[Cholangiocarcinoma historical perspective|Historical Perspective]] | [[Cholangiocarcinoma historical perspective|Historical Perspective]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Cholangiocarcinoma classification|Classification]] | |||
|- | |- | ||
! | ! | ||
Line 40: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma differential diagnosis|Differentiating Cholangiocarcinoma from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma natural history|Natural History, Complications | [[Cholangiocarcinoma natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 82: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma history and symptoms|History | [[Cholangiocarcinoma diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Cholangiocarcinoma history and symptoms|History and Symptoms]] | |||
|- | |- | ||
! | ! | ||
Line 94: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma laboratory tests| | [[Cholangiocarcinoma laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 118: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma x ray|X-ray]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 136: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma echocardiography or ultrasound| | [[Cholangiocarcinoma echocardiography or ultrasound|Echocardiography or Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 132: | Line 142: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma other imaging findings | [[Cholangiocarcinoma other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 143: | Line 149: | ||
! | ! | ||
[[Cholangiocarcinoma other diagnostic studies|Other Diagnostic Studies]] | [[Cholangiocarcinoma other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma medical | [[Cholangiocarcinoma medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 167: | Line 167: | ||
! | ! | ||
[[Cholangiocarcinoma surgery|Surgery]] | [[Cholangiocarcinoma surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 174: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 180: | Line 178: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 186: | Line 184: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 192: | Line 190: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |||
! | |||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Latest revision as of 17:50, 7 January 2019
Cholangiocarcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cholangiocarcinoma On the Web |
American Roentgen Ray Society Images of Cholangiocarcinoma |